What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review

What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review

Background: Obesity [defined as a body mass index (BMI) ≥ 30 kg/m2] represents a considerable public health problem and is associated with a significant range of comorbidities and an increased mortality risk. The primary aim of the management of obesity is to achieve weight reduction in the interest...

Full description

Bibliographic Details
Main Authors: R Ara, L Blake, L Gray, M Hernández, M Crowther, A Dunkley, F Warren, R Jackson, A Rees, M Stevenson, K Abrams, N Cooper, M Davies, K Khunti, A Sutton
Format: Article
Language:English
Published: NIHR Journals Library 2012-02-01
Series:Health Technology Assessment
Subjects:
orlistat
sibutramine
rimonabant
obesity
body mass index
systematic review
clinical effectiveness
cost-effectiveness
Online Access:https://doi.org/10.3310/hta16050

Similar Items

Similar Items